Zhang JY - Search Results

1

Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression.

Pan Z, Wang K, Wang X, Jia Z, Yang Y, Duan Y, Huang L, Wu ZX, Zhang JY, Ding X. Pan Z, et al. Among authors: zhang jy. Mol Cancer. 2022 Mar 18;21(1):77. doi: 10.1186/s12943-022-01547-3. Mol Cancer. 2022. PMID: 35303882 Free PMC article.

2

MED12 exerts an emerging role in actin-mediated cytokinesis via LIMK2/cofilin pathway in NSCLC.

Xu M, Wang F, Li G, Wang X, Fang X, Jin H, Chen Z, Zhang J, Fu L. Xu M, et al. Mol Cancer. 2019 May 9;18(1):93. doi: 10.1186/s12943-019-1020-4. Mol Cancer. 2019. PMID: 31072327 Free PMC article.

3

Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells.

Wu ZX, Teng QX, Cai CY, Wang JQ, Lei ZN, Yang Y, Fan YF, Zhang JY, Li J, Chen ZS. Wu ZX, et al. Among authors: zhang jy. Biochem Pharmacol. 2019 Aug;166:120-127. doi: 10.1016/j.bcp.2019.05.015. Epub 2019 May 9. Biochem Pharmacol. 2019. PMID: 31078601

4

Chloroquine against malaria, cancers and viral diseases.

Zhou W, Wang H, Yang Y, Chen ZS, Zou C, Zhang J. Zhou W, et al. Drug Discov Today. 2020 Sep 16;25(11):2012-22. doi: 10.1016/j.drudis.2020.09.010. Online ahead of print. Drug Discov Today. 2020. PMID: 32947043 Free PMC article. Review.

5

Pristimerin induces apoptosis and inhibits proliferation, migration in H1299 Lung Cancer Cells.

Li J, Guo Q, Lei X, Zhang L, Su C, Liu Y, Zhou W, Chen H, Wang H, Wang F, Yan Y, Zhang J. Li J, et al. J Cancer. 2020 Sep 2;11(21):6348-6355. doi: 10.7150/jca.44431. eCollection 2020. J Cancer. 2020. PMID: 33033518 Free PMC article.

6

Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer.

Wu S, Luo M, To KKW, Zhang J, Su C, Zhang H, An S, Wang F, Chen D, Fu L. Wu S, et al. Mol Cancer. 2021 Jan 18;20(1):17. doi: 10.1186/s12943-021-01307-9. Mol Cancer. 2021. PMID: 33461557 Free PMC article.

7

Elevated ABCB1 Expression Confers Acquired Resistance to Aurora Kinase Inhibitor GSK-1070916 in Cancer Cells.

Wu ZX, Yang Y, Wang JQ, Zhou WM, Chen J, Fu YG, Patel K, Chen ZS, Zhang JY. Wu ZX, et al. Among authors: zhang jy. Front Pharmacol. 2021 Jan 14;11:615824. doi: 10.3389/fphar.2020.615824. eCollection 2020. Front Pharmacol. 2021. PMID: 33519482 Free PMC article.

8

CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells.

Zhang L, Li Y, Hu C, Chen Y, Chen Z, Chen ZS, Zhang JY, Fang S. Zhang L, et al. Among authors: zhang jy. Mol Cancer. 2022 Apr 22;21(1):103. doi: 10.1186/s12943-022-01524-w. Mol Cancer. 2022. PMID: 35459184 Free PMC article.

9

Effect of lathyrol derivatives on non-small cell lung cancer and the possible mechanism.

Yan Y, Zhou W, Guo Q, Zhang H, Ji H, Yang L, Zhang J. Yan Y, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Feb 28;47(2):143-152. doi: 10.11817/j.issn.1672-7347.2022.210104. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 35545404 Free PMC article. Chinese, English.

10

A cell-based screen for anticancer activity of 13 pyrazolone derivatives.

Wang XH, Wang XK, Liang YJ, Shi Z, Zhang JY, Chen LM, Fu LW. Wang XH, et al. Among authors: zhang jy. Chin J Cancer. 2010 Dec;29(12):980-7. doi: 10.5732/cjc.010.10309. Chin J Cancer. 2010. PMID: 21114917 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,561 results

Search Page

Filters